MediFind found 86 doctor with experience in Hairy Cell Leukemia (HCL) near Maryland, US. Of these, 72 are Experienced, 12 are Advanced, 1 are Distinguished and 1 are Elite.
Robert Kreitman is a Hematologist Oncology provider in Olney, Maryland. Dr. Kreitman is rated as an Elite provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Hairy Cell Leukemia (HCL), Leukemia, Anaplastic Thyroid Cancer, and Reticuloendotheliosis.
Wyndham Wilson is an Oncologist in Bethesda, Maryland. Dr. Wilson is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Burkitt Lymphoma.
Sidney Kimmel Comprehensive Cancer Center
Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Transplant.
Maryland Oncology Hematology PA
John Wallmark is a Hematologist Oncology provider in Rockville, Maryland. Dr. Wallmark is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Multiple Myeloma, and Colorectal Cancer.
Maryland Oncology Hematology
Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain.
Johns Hopkins Bayview Medical Center
Dr. Ariel Green is Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include geriatric medicine and general internal medicine, with a particular interest in reducing use of potentially harmful medications in older adults. Dr. Green earned her medical degree, Master of Public Health and PhD in Clinical Investigation from Johns Hopkins University. She completed her residency in internal medicine at Johns Hopkins Bayview Medical Center and performed a fellowship in geriatric medicine at Johns Hopkins. Her research, supported by the National Institute on Aging, is evaluating the impact on patient and caregiver outcomes of pragmatic interventions to optimize prescribing for older adults with dementia in primary care. Dr. Green is a core faculty member of the Johns Hopkins Bloomberg School of Public Health Center for Drug Safety and Effectiveness. She is also a member of the American Geriatrics Society Clinical Practice and Models of Care Committee. She co-authored The American Geriatrics Society’s recommendations for Choosing Wisely, a national initiative that aims to promote conversations between patients and doctors about avoiding unhelpful medical tests and treatments. A former journalist, Dr. Green has published personal essays and op-eds in Annals of Internal Medicine, The Washington Post, and The New York Times, among other publications. She has been recognized with several awards, including the American Geriatrics Society Choosing Wisely Champion Award. Dr. Green is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Dementia, Microscopic Polyangiitis, Lewy Body Dementia (LBD), and Reticuloendotheliosis.
Center For Cancer & Blood Disorders
Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.
Maryland Oncology Hematology
Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia.
Maryland Oncology Hematology PA
"Shannon C. O'Connor, M.D., is a medical oncologist with Suburban Hospital. She practices out of Maryland Oncology Hematology. Dr. O'Connor has expertise in hematology and medical oncology with a special focus in women's health, including breast cancer and gynecologic cancers. Dr. O'Connor earned her Master's Degree in Physiology at Georgetown University, followed by her medical degree from St. George's University School of Medicine. She completed a residency at Washington Hospital Center, as well as a fellowship in hematology and oncology. Dr. O'Connor is a member of the American Society of Clinical Oncology, the American Society of Hematology, the Montgomery County Medical Society and the American Medical Association. Selected Publications Catlett JP1, Williams SA, O'Connor SC, Krishnan J, Malkovska V. ""Primary lymphoma of bone: an institutional experience."" Leuk Lymphoma. 2008 Nov;49(11):2125-32. doi: 10.1080/10428190802404030.". Dr. O'connor is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Paget Disease of the Breast, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Breast Cancer.
Maryland Oncology Hematology
As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant.
Sidney Kimmel Comprehensive Cancer Center
Dr. Sterling is an oncologist who cares for patients with hematologic malignancies at the Johns Hopkins University School of Medicine. He is an active clinician with expertise in lymphoma and bone marrow transplantation and serves as the Director of the Johns Hopkins Lymphoma and Myeloma Multidisciplinary Conference. Dr. Sterling earned his undergraduate degree in biomedical sciences from Auburn University and his medical degree from Johns Hopkins University. He completed his training in internal medicine and medical oncology at Johns Hopkins before being recruited to the faculty. As a clinical investigator, Dr. Sterling's research focuses on the development of new technologies, therapies, and treatment strategies for lymphoma and other conditions treated with bone marrow transplantation. Dr. Sterling is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, T-Cell Lymphoma, and Peripheral T-Cell Lymphoma.
Chesapeake OncologyHematology
Arun Bhandari, M.D. is a native of Maryland and grew up in Silver Spring area. He earned his medical degree from Punjabi University and Government Medical College, Punjab, India and completed his internship and residency in Internal Medicine at New York University program in Queens, NY. He completed his Hematology and Oncology fellowship at University of Tennessee Health Science Center, Memphis, TN, Georgetown University and Washington Hospital Center, Washington, DC and NHLBI at National Institute of Health, Bethesda, MD. He served as a chief fellow at Georgetown University and Washington Hospital Center, Washington, D.C. After completing his fellowship in 2005, he joined as faculty at Allegheny General Hospital in Pittsburgh, PA, where he was actively involved in teaching fellows and residents. He joined COHA in 2007 at which time he opened a location in Annapolis and Kent Island. He has interest in head and neck cancer, brain cancer, breast cancer, lung cancer, gastrointestinal cancer(colon, pancreas, liver, gastric, esophageal etc.), genitourinary cancer (kidney, prostate, bladder etc.), gynecological cancer (ovarian, uterine, cervical, vaginal etc.), skin cancer, Lymphoma, Myeloma, Leukemia and various other blood disorders. He is a member of the American Society of Clinical Oncology and American Society of Hematology. He currently sees patients at Annapolis Cancer Center and Kent Island Center. He speaks English, Hindi, and Punjabi. Dr. Bhandari is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Pleuropulmonary Blastoma, Multiple Myeloma, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.
Maryland Oncology Hematology
Learn more at marylandoncology.com. Dr. Sastry is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.
Johns Hopkins Outpatient Center
Dr. Stephen D. Sisson is a professor of medicine at the Johns Hopkins University School of Medicine. Dr. Sisson’s area of clinical expertise is internal medicine. He serves as vice president of clinical operations for the Office of Johns Hopkins Physicians, and as director of the Johns Hopkins Physician Education and Assessment Center (PEAC). He is the Philip A. Tumulty Professor of Medicine. Dr. Sisson holds a B.S. in chemistry from Duke University. He earned his M.D. (Alpha Omega Alpha, with research honors) at Tufts University School of Medicine. He completed an internal medicine internship and residency at Johns Hopkins, serving as assistant chief of service for the Barker Firm. He joined the Johns Hopkins faculty in 1996. He served for 15 years as the associate director of the Osler Medical Housestaff Training Program. His research interests include community outreach, medical education and ambulatory care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sisson is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are COVID-19, Cerebral Palsy, Acute Eosinophilic Pneumonia, and Hypereosinophilic Syndrome.
Johns Hopkins Bayview Medical Center
Julie R. Brahmer, M.D., M.Sc. is the Director of the Thoracic Oncology Program, Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Marilyn Meyerhoff Professor in Thoracic Oncology. She also directs the Kimmel Cancer Center on the Johns Hopkins Bayview campus and is co-principal investigator on Johns Hopkins' National Clinical Trials Network. Dr. Brahmer received her undergraduate degree in Chemistry and Philosophy in 1989 from the Creighton University in Omaha, Nebraska and went on to receive her medical degree from the University of Nebraska Medical Center College of Medicine in 1993. Completing her internship and residency in Internal Medicine at the University of Utah, Dr. Brahmer later became the Chief Medical Resident until moving to Baltimore to complete her fellowship in Medical Oncology at the Kimmel Cancer Center at Johns Hopkins. Dr. Brahmer is an active clinical leader in the treatment of lung cancer and mesothelioma. She leads the organization of the multidisciplinary thoracic malignancy conference whose members meet weekly to discuss thoracic malignancy cases that need a multidisciplinary review/approach. Dr. Brahmer's research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. Dr. Brahmer's research interests include leading early phase immunotherapy trials of anti-PD-1 antibodies, international phase III studies of immunotherapies in lung cancer and investigator-initiated trials evaluating epigenetic therapies in combination with immunotherapies. She is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee and Cancer Prevention Steering Committee. She is one of the founding Board members for the National Lung Cancer Partnership (formerly Women Against Lung Cancer). Within the National Lung Cancer Partnership, she currently serves as a member and the Chairman of the Scientific Executive Committee. She is also on the medical advisory board of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation. Dr. Brahmer is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
UPMC Hillman Cancer Center At UPMC Western Maryland
Blanche Mavromatis is an Oncologist in Cumberland, Maryland. Dr. Mavromatis is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Mavromatis is currently accepting new patients.
Chesapeake Oncology Hematology Assoc
Gayatri Nimmagadda is a Hematologist and a Hematologist Oncology provider in Columbia, Maryland. Dr. Nimmagadda is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Pleuropulmonary Blastoma.
Skip Viragh Outpatient Cancer Center
Eric Christenson is an Oncologist in Baltimore, Maryland. Dr. Christenson is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Cholangiocarcinoma (Bile Duct Cancer).
Maryland Oncology Hematology PA
"George A. Sotos, M.D., is the chief of hematology and oncology at Suburban Hospital, as well as a member of Suburban's Cancer Committee and the coordinator of Multidisciplinary Cancer Conferences. Dr. Sotos is a partner of Maryland Oncology & Hematology in Rockville, Maryland. Dr. Sotos has expertise in medical oncology and hematology, as well as chemotherapy. Dr. Sotos earned his Master of Science in Physiology from Georgetown University, followed by his medical degree from the Medical College of Virginia. He completed a residency in internal medicine with University of Texas Southwestern Medical Center, followed by a fellowship in medical oncology with the National Cancer Institute of the National Institutes of Health. Dr. Sotos is a fellow of the American College of Physicians, as well as a member of the Montgomery County Medical Society, the Medical and Chirurgical Faculty of the State of Maryland, and the American Society of Clinical Oncology. He is also a member of the oncology specialty panel for Johns Hopkins Medicine's Formulary Management Committee and previously served as a member of Suburban Hospital's Medical Staff Executive Committee, Provider Quality Committee and Physician Advisory Board. Dr. Sotos has been named a Top Doctor by Washington Consumers' Checkbook and a Super Doctor by the Washington Post magazine. Castle Connolly has also named him a Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas. Dr. Sotos has contributed to numerous publications on medical oncology and hematology topics. Selected Publications Rotello, L, Albrant, D, Nossuli, K, Sotos, G, Samet, C, Rainey, T. ""Impact of a Hospital-Wide Pharmacy Implemented Weight-Based Dosing Protocol for Erythropoietin."" Chest, 124:4 (Suppl):182S (Abstract), 2003. Sotos, George A. ""Ars Brevis."" Journal of Clinical Oncology, 2013; 31:14; 1792-1794; http://jco.ascopubs.org/content/31/14/1792.full.pdf+html". Dr. Sotos is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Multiple Myeloma, and Endometrial Cancer.
The Johns Hopkins Hospital
Ravin Garg is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura.
Last Updated: 01/09/2026















